Biotricity, Inc.BTCYNASDAQ
Loading
R&D Expenses Over TimeExpanding
Percentile Rank75
3Y CAGR-8.2%
5Y CAGR+3.9%
Studio
Year-over-Year Change

Research and development spending

3Y CAGR
-8.2%/yr
vs +25.3%/yr prior
5Y CAGR
+3.9%/yr
Recent deceleration
Acceleration
-33.6pp
Decelerating
Percentile
P75
Within normal range
vs 5Y Ago
1.2x
Modest growth
Streak
1 yr
Consecutive growthExpanding
PeriodValueYoY Change
TTM$2.50M+15.7%
2025$2.16M-16.2%
2024$2.57M-20.4%
2023$3.23M+17.7%
2022$2.74M+33.3%
2021$2.06M+51.0%
2020$1.36M+4.1%
2019$1.31M-25.7%
2018$1.76M+54.8%
2017$1.14M-